Interpace Diagnostics

Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, is a leading provider of molecular testing for thyroid nodules. The Company offers ThyGeNEXT® + ThyraMIR®v2, a unique combination testing platform that utilizes both mutational and microRNA markers to risk-stratify indeterminate thyroid nodules. Test results help aid patient management decisions regarding the need for, and extent of, surgery and inform when mutations and fusions aligned to FDA-approved targeted therapies are found.